2006
DOI: 10.1002/anie.200502770
|View full text |Cite
|
Sign up to set email alerts
|

NMR Characterization of Kinase p38 Dynamics in Free and Ligand‐Bound Forms

Abstract: In its apo state kinase p38 effects slow motions that can be detected in the NMR spectrum. One of the affected parts is the pharmacologically interesting DFG motif. Diarylurea inhibitors that bind to the DFG‐out conformation lock this motif in a defined state, whereas DFG‐in inhibitors that bind to the adjacent hinge region leave the flexibility of the DFG motif unaffected (see crystal structure of the complex of p38 with the inhibitor SB203580).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

14
156
0

Year Published

2006
2006
2015
2015

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 145 publications
(170 citation statements)
references
References 27 publications
14
156
0
Order By: Relevance
“…This suggestion is supported by the recent results showing that unphosphorylated Abl kinase can be crystallized in both ''DFG in'' and ''DFG out'' forms (20), suggesting that the inactive ''DFG in'' conformation is an intermediate state between the active and the ''DFG out'' conformation. NMR study of the p38 kinase apo form in its dephosphorylated state has also demonstrated that it dynamically changes its conformation between ''DFG in'' and ''DFG out'' configurations, proving that the magnesium-binding loop in inactive kinases can be remarkably flexible (21).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…This suggestion is supported by the recent results showing that unphosphorylated Abl kinase can be crystallized in both ''DFG in'' and ''DFG out'' forms (20), suggesting that the inactive ''DFG in'' conformation is an intermediate state between the active and the ''DFG out'' conformation. NMR study of the p38 kinase apo form in its dephosphorylated state has also demonstrated that it dynamically changes its conformation between ''DFG in'' and ''DFG out'' configurations, proving that the magnesium-binding loop in inactive kinases can be remarkably flexible (21).…”
Section: Resultsmentioning
confidence: 99%
“…Recent studies (20,21) have demonstrated that, in inactive Abl and p38 kinases, the DFG motif was extremely flexible, flipping between ''DFG in'' and ''DFG out'' conformations. Our model is in a good correspondence with these facts because it suggests not only relaxation of the magnesium-binding loop, but also disruption of a connection between the lobes, that has to facilitate such conformational changes.…”
Section: Discussionmentioning
confidence: 99%
“…As a negative control, we have also performed fluorescence experiments using the DFG-in binder dasatinib (38,39). It is thought that so-called DFG-in binders typically bind to both DFG-in and DFG-out conformations (13). We find only a very weak pH dependence for dasatinib binding (Fig.…”
Section: Probing the Dfg-out Conformation By Using Abl-imatinib Bindingmentioning
confidence: 94%
“…However, it is very challenging to directly probe the dynamics of this motif experimentally (13). Molecular dynamics (MD) simulation provides an alternative means to study kinase dynamics (14)(15)(16), but the time scale accessible to such studies has typically been restricted to between 100 ps and 10 ns.…”
mentioning
confidence: 99%
“…Similarly, this suggests that imatinib could also temporarily bind in an ATP-competitive manner to Abl and uses the opportunity provided by spontaneous conformational changes to switch to its known Type II binding mode. The observation of two alternative binding modes for the Type I inhibitor BIM-2 in PKC [92], and of two different binding modes for a imidazole-pyridine inhibitor to the active and inactive conformations of p38a further supports this hypothesis of temporary binding modes [93]. Such a mechanism could explain the observation that a drug-resistant gatekeeper mutant of Src can be bound by certain irreversible 4-aminoquinazoline-based inhibitors, but not by their reversible counterparts [94].…”
Section: Kinase Inhibitors and Conformational Changesmentioning
confidence: 61%